Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 10, 2026, 11:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 189 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Implantable Cardioverter Defibrillator Implanted Clear all

Conditions: Heart Failure
Interventions: Monthly Review Arm, Quarterly Review Arm; Other
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 1,682 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 108
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 105 more

Conditions: Chronic Heart Failure
Interventions: BAY2413555 Dose 1, BAY2413555 Dose 2, Placebo to BAY2413555; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia • Silver Spring, Maryland • Camp Hill, Pennsylvania

Conditions: Heart Disease, Cardiovascular Disease, Heart Failure, Arrhythmias, Cardiac
Interventions: Unpaired remote monitoring transmitter; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Zanesville, Ohio

Conditions: MRI Scans, Magnetic Resonance Imaging, Pacemaker, Implantable Cardioverter Defibrillator
Interventions: MRI Scan; Other
Lead sponsor: Lancaster General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Lancaster, Pennsylvania

Conditions: Implantable Cardioverter-Defibrillator, Health Information Exchange, Electronic Health Records, Patient Participation
Interventions: Receive Detailed ICD Information-electronic, Receive Detailed ICD Information-paper; Other
Lead sponsor: Parkview Hospital, Indiana; Other
Eligibility: 18 Years and older
Enrollment: 191 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Arrhythmias
Interventions: azimilide dihydrochloride; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 50
States / cities: Mobile, Alabama • Little Rock, Arkansas • La Jolla, California + 43 more

Conditions: Ventricular Tachycardia
Interventions: MRI guided VT ablation, Increased dose of amiodarone; Procedure · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Tachycardia, Ventricular, Ventricular Fibrillation
Interventions: Methods for monitoring patients with ICD's; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Ventricular Arrhythmia, Implantable Cardioverter Defibrillator
Interventions: Quality of Life Therapy (QOLT), Heart Healthy Education (HHE); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Pacemaker, Implantable Cardioverter Defibrillators
Interventions: MRI; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 872 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Systolic Heart Failure, Sudden Cardiac Death
Interventions: ICD Decision Aid Toolkit; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: Cardiovascular Disease
Interventions: Therapy Programming Report (TPR); Behavioral
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: Not listed
Enrollment: 4,384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 83
States / cities: Anniston, Alabama • Phoenix, Arizona • Tucson, Arizona + 80 more

Conditions: Sarcoidosis of the Heart, Cardiomyopathy
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Coronary Artery Disease, Hypertension, Dyslipidemia, Diabetes
Interventions: magnesium L-lactate; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Tachyarrhythmias, Sudden Cardiac Death, Heart Failure
Interventions: SJ4 connector and RV high voltage SJ4 lead; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,701 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Arrhythmia, Quality of Life, Hypomagnesemia
Interventions: Magnesium L-lactate; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Catecholaminergic Polymorphic Ventricular Tachycardia
Interventions: Flecainide Acetate, Placebo, Beta blocker; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 5 Years to 99 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 10
States / cities: Los Angeles, California • Orange, California • New York, New York + 7 more

Conditions: Heart Failure
Interventions: LMI 1195; Drug
Lead sponsor: Lantheus Medical Imaging; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Congestive Heart Failure
Interventions: EnSite NavX System; Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 2
States / cities: Augusta, Georgia • Durham, North Carolina

Conditions: Heart Failure, Systolic, Heart Failure
Interventions: Educational video and/or handout; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 790 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Wound, Cardiac Arrhythmia
Interventions: Zip Surgical Skin Closure Device, Standard Suture Closure; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy, Heart Failure
Interventions: Ranolazine; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older
Enrollment: 1,012 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 83
States / cities: Tucson, Arizona • Little Rock, Arkansas • East Palo Alto, California + 70 more

Conditions: Heart Failure
Interventions: Thyroid hormone T3, Control Group; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Heart Failure
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

OptiVol® Care Pathway

A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)

Remote Device Interrogation In The Emergency Department

Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD

Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagement on Outcomes in the Merlin.Net™

Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)

Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia

A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic

Positive Therapy for Autonomic Function & Mood in ICD Patients

Study Evaluating the Use of MRI on CMS Patients

A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

Medtronic Shock-Less Study on Physician Utilization of Shock Reduction Programming

Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis

The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.

Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing

EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant

A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators

ZIPS Study - Zip Incision aPproximation vs. Suture

Ranolazine Implantable Cardioverter-Defibrillator Trial

Effects of Triiodothyronine (T3) in Ischemic Heart Failure

Implantable Cardioverter Defibrillator (ICD) Function During Ventricular Assist Device (VAD) Implantation